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Abstract
Background: Mutation of Wnt signal antagonists Apc or Axin activates b-catenin signaling in many cancers including the
majority of human colorectal adenocarcinomas. The phenotype of apc or axin mutation in the fruit fly Drosophila
melanogaster is strikingly similar to that caused by mutation in the segment-polarity gene, naked cuticle (nkd). Nkd inhibits
Wnt signaling by binding to the Dishevelled (Dsh/Dvl) family of scaffold proteins that link Wnt receptor activation to b-
catenin accumulation and TCF-dependent transcription, but human NKD genes have yet to be directly implicated in cancer.
Methodology/Principal Findings: We identify for the first time mutations in NKD1 - one of two human nkd homologs - in a
subset of DNA mismatch repair-deficient colorectal tumors that are not known to harbor mutations in other Wnt-pathway
genes. The mutant Nkd1 proteins are defective at inhibiting Wnt signaling; in addition, the mutant Nkd1 proteins stabilize b-
catenin and promote cell proliferation, in part due to a reduced ability of each mutant Nkd1 protein to bind and destabilize
Dvl proteins.
Conclusions/Significance: Our data raise the hypothesis that specific NKD1 mutations promote Wnt-dependent
tumorigenesis in a subset of DNA mismatch-repair-deficient colorectal adenocarcinomas and possibly other Wnt-signal
driven human cancers.
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Introduction
Activation of ‘‘canonical’’ Wnt/b-catenin signaling in nearly all
human colorectal adenocarcinomas (CRC) makes the Wnt
pathway a promising yet untapped therapeutic target [1]. The
prevailing paradigm for canonical Wnt signaling was deduced in
part through elegant developmental studies of the fruit fly
Drosophila melanogaster and the amphibian Xenopus laevis: Absent
the Wnt signal, a ‘‘destruction complex’’ composed of the proteins
Apc, Axin, GSK3b, and CK1 phosphorylates b-catenin, leading to
b-catenin ubiquitination and proteasomal degradation [2].
Binding of Wnt ligands to Frizzled/Lrp coreceptors activates the
scaffold protein Dishevelled (Dsh; Dvl1, Dvl2, Dvl3 in mammals),
leading to sequestration and degradation of Axin, which allows b-
catenin to accumulate, enter the nucleus, and bind TCF
transcription factors to regulate target genes [2].
A majority (60–85%) of human CRC exhibit activated
canonical Wnt signaling due to truncating mutations in APC that
stabilize b-catenin [3]. Alternatively, mutations in b-catenin
(CTNNB1) that block phosphorylation and degradation are found
in some CRC that lack APC mutation [4]. CRCs display at least
two types of genomic instability: chromosomal instability (CIN)
associated with mutant Apc and p53 and giving rise to aneuploidy,
and microsatellite-instability (MSI) caused by defective DNA
mismatch repair (MMR) and resulting in mutations in simple
sequence repeats (SSR) throughout the genome [5,6]. Mutation of
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genes can create point mutant or truncated proteins that promote
cancer progression; indeed, MMR deficiency and MSI are
characteristic of tumors in patients with hereditary nonpolyposis
colorectal cancer syndrome {HNPCC; a.k.a. Lynch Syndrome
(OMIM 120435)} and of 13–17% of sporadic CRC [7]. APC
mutations are prevalent in CIN-CRC [3], but the Wnt pathway
gene mutation spectrum in MSI-CRC is less well characterized,
with mutations in the Axin homolog AXIN2 and the TCF-family
transcription factor TCF7L2 identified in ,25% and ,35% of
MSI-CRC, respectively [8,9]. APC mutation is less frequent in
MSI-CRC than in CIN-CRC [10,11], while activating mutations
in CTNNB1, though widespread throughout the spectrum of
human cancer, are rare in MSI-CRC [11]. These data suggest that
additional mechanisms activate Wnt/b-catenin signaling in MSI-
CRC.
The Naked cuticle (Nkd) protein family attenuates canonical Wnt
signaling by binding and possibly destabilizing Dsh/Dvl proteins
[12–17]. Drosophila nkd mutants develop lethal segmentation defects
very similar to those seen in apc or axin mutants [12,18,19] (Fig. 1A).
We therefore hypothesized that alteration of nkd gene activity in
mammals might activate Wnt signaling and cause cancer. Here we
identify novel mutations in the human NKD1 gene in MSI-CRC
that alter Wnt signaling and reduce Nkd/Dsh interactions. Our
data suggest that specific NKD1 mutations alter Wnt/b-catenin
signaling in a minority of MSI-CRC as well as possibly in other b-
catenin signal-dependent tumors in which mutations in the known
Wnt regulators are infrequent.
Figure 1. Nkd mutations in fly and human. (A) Wild-type, axin, apc, and nkd Drosophila cuticles. Wild type has alternating denticle bands (arrow)
and naked cuticle (arrowhead), with each mutant lacking denticle bands. (B) NKD1 locus has 10 exons. Nkd1 schematic (orange) includes N-terminal
myristoylation, EFX, 30aa (blue), and carboxy-terminal His-rich motifs. Exon 10 sequences around poly-(C) tracts (red) above native (black) and mutant
(blue) residues are shown. (C) NKD1 electropherograms showing wild-type (WT) poly-(C)7, cell line TC7 with C-deletion (C6), cell line RKO with C-
insertion (C8), and cell line HCT15 with G.A mutation (arrow) 39 of poly-(C)7. (D, E) a-Nkd1 blots of whole cell extracts (D) and Triton X-100 soluble
and insoluble fractions (E) from cell lines with indicated NKD1 mutation. Arrows designate Nkd1 proteins. b-actin is loading control in D. CCD841 has
full length Nkd1, with a minor degradation product at ,35 kDa also seen with transfected NKD1 (e.g. Fig. 1E, 5C), whereas SW480 with more
abundant but wild-type Nkd1 has several degradation products.
doi:10.1371/journal.pone.0007982.g001
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NKD1 mutations in colorectal adenocarcinoma
We identified three different NKD1 exon 10 coding region
mutations in 5/11 CRC cell lines and 2/40 sporadic CRC tumors
with MSI (Table 1), but no NKD1 coding region or splice junction
mutations in 5/5 CRC cell lines and 50/50 tumors without MSI.
Two mutations, either a deoxycytidine (C) deletion or insertion
due to polymerase slippage within an exon-10 poly-(C)7 tract,
result in the synthesis of truncated proteins of 345 or 298 amino
acids (aa)(Fig. 1B,C). A (C)7-adjacent missense mutation (G.A)
converts Arg-288, conserved in Nkd2, to His (Fig. 1B,C). NKD1
mutations were not detected in 32/40 MSI-CRC tumors that
harbor mutations in other Wnt-pathway genes including APC,
CTNNB1, AXIN2, and TCF7L2, but were found in 2 of the
remaining 8/40 tumors without lesions in these known Wnt-
pathway genes (p=0.036, one-tailed Fisher’s exact test) (Table 1;
see Materials and Methods). These data indicate a mutual
exclusivity among mutations in NKD1 and other Wnt-pathway
genes in our cohort of MSI-CRC tumor samples, suggesting that
the NKD1 mutations are of pathological significance.
Both the colonic epithelial cell line CCD841 and the CRC cell
line SW480, the latter with a C.T mutation at APC codon #1338
[20], encode a wild-type Nkd1 (470 aa) of 53.2 kDa that migrates
at ,50 kDa on western blot (Fig. 1D, E). Cell lines Co115 and
TC7, each with the (C)6 mutation, have a ,39 kDa band that
corresponds to the 38.1 kDa Nkd1
C6, while cell line RKO, with
the (C)8 mutation, has a ,33 kDa band that corresponds to the
33.4 kDa Nkd1
C8; all three cell lines with truncated Nkd1 also
have less abundant full-length Nkd1, suggesting that the wild-type
NKD1 locus does not undergo loss-of-heterozygosity (Fig. 1D). By
western blot with Nkd1 antibodies we are unable to distinguish
wild-type from mutant Nkd1 in cell line HCT15, which harbors
NKD1
R288H (Fig. 1D).
Nkd proteins are membrane-associated, the mammalian Nkds by
virtueof N-terminal myristoylation [14,21,22]. The truncated Nkd1
proteins have a reduced affinity for membranes compared to full-
length Nkd1 as inferred by Triton X-100 solubility: 95% of Nkd
C6
or Nkd
C8 from mutant cell lines is TX-100 soluble, whereas 0–26%
of full-length Nkd1 from all cell lines is TX-100 soluble (Fig. 1E).
Mutant Nkd1 proteins are defective at inhibiting Wnt/Dvl
signaling
Mouse Nkd1 can inhibit axis duplication induced by ectopic
Wnt signaling in Xenopus embryos [16]. As shown in Fig. 2A,
Table 1. Wnt-pathway genetic lesions in MSI colon tumors
and cell lines.
Tumor ID NKD1 AXIN2 TCF7L2 CTNNB1 APC
CT1 2 1994ins G A8/A9 22
CT2 22 A8/A9 22
CT3 22 A8/A9 22
CT4 2 1994ins G 22 2
CT5 22 A8/A9 2 T
CT6 22 22 2
CT7 22 A8/A9 2 T
CT8 872del C 22 2 2
CT9 22 2M 2
CT10 22 A8/A9 22
CT11 22 A8/A9 22
CT12 22 22 T
CT13 2 1994ins G 22 2
CT14 22 22 2
CT15 2 2023del C 22 2
CT16 22 22 T
CT17 2 1994ins G A8/A9 22
CT18 22 A8/A9 22
CT19 2 2011del C 22 2
CT20 22 22 2
CT21 2 1925ins A 22 2
CT22 22 2M 2
CT23 22 2M 2
CT24 22 22 2
CT25 22 A8/A9 22
CT26 22 A8/A9 22
CT27 872del C 22 2 2
CT28 22 A8/A9 22
CT29 22 A8/A9 22
CT30 2 1994del G 22 2
CT31 22 A8/A9 22
CT32 22 2M 2
CT33 2 1994del G 22 2
CT34 22 A8/A9 22
CT35 22 2M 2
CT36 22 22 2
CT37 22 A8/A9 22
CT38 22 A8/A9 22
CT39 22 22 2
CT40 22 A8/A9 22
Cell line NKD1 AXIN2 TCF7L2 CTNNB1 APC
Co115 872del C 22 2 2
LS174T 22 A8/A9 + 2
LoVo 22 A8/22 +
TC71 22 A8/22 +
HCT15 873G.A 22 2 +
HCT116 2 1994del G 2 + 2
TC7 872del C 2 A8/A9 2 +
Cell line NKD1 AXIN2 TCF7L2 CTNNB1 APC
SW48 22 2+ 2
RKO 872ins C 22 2 2
HCT8 22 22 2
LS411 872ins C 22 2 +
NKD1, AXIN2, TCF7L2, CTNNB1,a n dAPC gene mutation status in 40 MSI-CRC
tumors (top) and 11 cell lines (bottom). Key: 2, no lesion; ins, nucleotide
insertion; del, nucleotide deletion; /2, allelic deletion. For NKD1 and AXIN2,
mutation in indicated nucleotide is designated, while for TCF7L2 the status of
the poly(A) tract (A8–wild-type; A9–mutant) is designated. CTNNB1 exon-3 was
screened for activating mutations (M). For APC, tumors positive for protein-
truncation (T) are indicated [45]. Presence (+) or absence (2)o fAPC and
CTNNB1 lesions in each cell line is as described [48].
doi:10.1371/journal.pone.0007982.t001
Table 1. Cont.
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partial-to-complete axis duplication; consistent with Nkd1’s
activity as a Wnt antagonist, wild-type human NKD1 mRNA co-
injection reduced axis duplication frequency to 42%, with only 3%
complete duplications. In contrast, co-injection of each mutant
human NKD1 resulted in axis duplication frequencies similar to
that observed with XWnt8 injection alone (Fig. 2A). As in cell lines,
misexpressed Nkd1
C6 and Nkd1
C8 were more abundant than wild-
type Nkd1 or Nkd1
R288H by western blot (not shown). In
agreement with the Xenopus results, wild-type Nkd1, but none of
the three mutants, suppressed Dvl-induced activation of the TCF-
reporter TOPflash in HEK-293 cells (Fig. 2B). Expression of
mutant Nkd1 alone slightly increased basal TOPflash activity and
had no effect on endogenous Xenopus axis formation (not shown),
indicating that the effect of Nkd1, like that of nkd in the fly,
depends on Wnt signaling [23].
NKD1 mutations stabilize b-catenin and promote cell
proliferation
Consistent with the NKD1 mutations activating Wnt signaling in
CRC, cytoplasmic and nuclear levels of b-catenin are higher in
Co115 cells than in CCD841 cells (Fig. 3A). Accordingly, nuclear
b-catenin was prominent in Co115 cells but not in CCD841 cells
(Fig. 3B, C). HEK-293T cells transfected with Nkd1
C6, Nkd1
C8,o r
Nkd1
R288H had higher levels of cytosolic b-catenin than cells
transfected with wild-type Nkd1 or a control (Fig. 3D), indicating
that each mutant Nkd1 protein can stabilize b-catenin.
Since canonical Wnt signaling promotes cell proliferation [2], we
assayed the accumulation of cells uniformly expressing comparable
levels of either wild-type or mutant Nkd1. Retroviral expression of
each mutant Nkd1 protein in CCD841 cells increased cell numbers
compared to wild-type Nkd1 or empty vector control (Fig. 3E).
Conversely, expression of wild-type Nkd1 in Co115 cells reduced
cell numbers (Fig. 3F). These data indicate that the NKD1 mutations
can promote b-catenin stabilization and colonic cell proliferation.
Altered subcellular localization and Dvl colocalization of
truncated Nkd1
We were unable to detect endogenous Nkd1 in cell lines by
immunocytochemistry, so to further investigate the relationship
between Nkd1 localization and activity we examined the
localization of tagged proteins in HEK-293 cells. Nkd1 localizes
in a punctate, predominantly cytoplasmic distribution similar to
Drosophila Nkd
GFP when expressed in fly salivary gland (Fig. 4A, F).
In contrast, Nkd1
C6 and Nkd1
C8 distribute diffusely in cytoplasm
(Fig. 4B and not shown), consistent with their enhanced detergent
solubility relative to Nkd1 (Fig. 1E), while Nkd1
R288H aggregates
like wild-type Nkd1 (not shown).
Dvl proteins localize to dynamic, cytoplasmic and plasma
membrane-associated aggregates that have been proposed to
amplify Wnt/b-catenin signaling [24]. Consistent with in vitro
Nkd/Dsh association, expression of Nkd1
GFP in HEK-293 cells or
fly Nkd
GFP in salivary gland gave rise to intracellular aggregates
with colocalized Nkd and Dsh/Dvl (Fig. 4C–C0, F–F0, and not
shown). In contrast, each Dvl co-synthesized with each truncated
Nkd1
GFP (C6 or C8) formed aggregates, but colocalization was
instead observed at aggregate interfaces, with Dvl aggregates
typically surrounding truncated Nkd1 aggregates (Fig. 4D–D0 and
not shown). Although the significance of these localizations vis-a `-
vis Wnt signaling is unclear, the truncated Nkd1 proteins identified
in CRC exhibited a reduced ability to colocalize with Dvl proteins
as compared to full-length Nkd1.
Mutant Nkd1 proteins are defective at binding Dvl
proteins
Next we investigated the biochemical mechanism of defective
Wnt signal inhibition by mutant Nkd1 proteins. The Nkd EFX
motif binds the basic/PDZ region of Dsh/Dvl proteins [14].
Surprisingly, each Nkd1 mutant, despite having an intact EFX
motif, bound each Dvl protein less than wild-type Nkd1 by yeast-
two-hybrid (Y2H) assay (Fig. 5A). Nkd1 truncation at the (C)7-tract
(Nkd1
1–286) also reduced Dvl binding (Fig. 5A), indicating that
reduced Dvl binding was not due to frameshift-induced unique C-
termini in the two truncated mutants. Each truncated Nkd1 protein
retains near its C-terminus a 30aa amphipathic a-helical motif that
is highly conserved (28/30 aa) in Nkd2 [14]. In fly Nkd, a similarly
positioned 30aa motif is critical for function and nuclear localization
[25], but the role of the 30aa motif in vertebrate Nkd proteins
remains unknown. Deletion of the 30aa motif in Nkd1
1–286 restored
Dvl binding, whereas further deletion of the EFX motif eliminated
Dvl binding (Fig. 5A). These data suggest that one function of the
Figure 2. Wild-type Nkd1 but not mutant Nkd1 inhibits Wnt/b-catenin signaling. (A) % Xenopus embryos with indicated axis phenotype
after injection of XWnt8+/2wild-type or mutant NKD1. (n)=# embryos injected. Panels at right show representative lateral (L) and dorsal (D) views of
embryos scored as single axis (white), short A/P axis (light gray), partial axis duplication (dark gray), and full axis duplication (black) according to the
Materials and Methods. In embryos with single axis in the left panels, note trunk (white arrow) and cement gland (black arrow). Arrowheads designate
each axis in embryos with axis duplications (right panels). Embryos with partial axis duplication have duplicated trunk tissue but a single cement
gland, while embryos with full axis duplication have duplicated trunk tissues and cement glands. (B) Normalized TOPflash luciferase activity (RLU) in
HEK-293 cells transfected with reporter +/2Dvl2 +/2 indicated Nkd1 construct.
doi:10.1371/journal.pone.0007982.g002
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tions, which is itself apparently opposed by further C-terminal
sequence that is deleted in our MSI-CRC tumors.
We confirmed the Y2H results by GST-pulldown and
coimmunoprecipitation experiments. As shown in Fig. 5B, each
Dvl protein exhibited reduced binding to GST-Nkd1
C6 and GST-
Nkd1
C8 as compared to wild-type GST-Nkd1, while GST-
Nkd1
R288H showed reduced associations with Dvl1 and Dvl2,
but less so with Dvl3, similar to that seen by Y2H. When expressed
in HEK-293 cells, Nkd1
C6 and Nkd1
C8 accumulated to higher
levels than Nkd1 and Nkd1
R288H (not shown); by normalizing
input lysates so that equal amounts of wild-type Nkd1 and each
mutant Nkd1 protein were immunoprecipitated, we observed a
two-fold reduction in the amount of Dvl3 co-immunoprecipitated
by Nkd1
C6 or Nkd1
C8 as compared to Nkd1 or Nkd1
R288H
(Fig. 5C). Thus, the NKD1 mutations reduce Nkd1/Dvl associa-
tions in vitro and in vivo.
Mutant Nkd1s are defective at altering Dvl levels
Dvls can be ubiquitinated and degraded by the proteasome, and
the binding of Nkd or other Dvl-binding proteins leads to Dvl
turnover [17,26–28]. The NKD1 mutations might therefore
compromise the ability of Nkd1 to destabilize Dvls. By expressing
Drosophila Nkd
GFP at different levels in adjacent cells of the third-
instar Drosophila salivary gland, we consistently observed an inverse
relationship between levels of Nkd
GFP and Dsh (Fig. 6A–A0). Since
dsh transcription is not known to be regulated in Drosophila, Nkd
GFP
is likely destabilizing Dsh, as observed when Nkd1 was
overexpressed in cultured mammalian cells [17]. Next, we co-
transfected wild-type or each mutant Nkd1 with Dvl1, Dvl2, or
Dvl3 into HEK-293 cells and examined the levels of each Dvl
protein by western blot. As shown in Fig. 6B, Dvl1 and Dvl2, and
to a lesser extent Dvl3, were less abundant when co-expressed with
wild-type Nkd1 than when expressed alone. Neither empty-vector
nor co-expressed GFP affected the levels of each Dvl (not shown).
In contrast, the amount of Dvl1 detectable with co-expression of
each mutant Nkd1 was similar to the Dvl1-only transfected control
(Fig. 6B). Dvl2 levels were partially reduced by each mutant Nkd1,
while Dvl3 levels were reduced less by coexpression of either
truncated Nkd1 than by wild-type Nkd1. Similar to the inverse
relationship between Nkd
GFP and Dsh levels in Drosophila salivary
gland (Fig. 6A–A0), fine punctate Dvl1 immunoreactivity in cells
with high levels of Nkd1
GFP appeared reduced compared to
adjacent cells with lower levels of Nkd1
GFP (Fig. 6C,C9). Taken
together, our data support the hypothesis that the specific
alteration of Nkd1’s ability to promote Dvl turnover might
activate Wnt/b-catenin signaling during CRC tumor progression.
Discussion
Mutation of the tumor suppressor APC elevates Wnt/b-catenin
signaling in the majority of the .1 million new cases of CRC
diagnosed annually world-wide [3,29]. We hypothesized that
mutations in other Wnt antagonists might elevate signaling in the
subset of CRC, particularly MSI-CRC, without mutations in
known Wnt regulators. We report three cancer-associated human
NKD1 mutations that alter Wnt/b-catenin signaling and disrupt
Nkd1/Dvl binding. Based on the frequency of NKD1 mutation
(5%) identified in our cohort of MSI-CRCs, we estimate that
NKD1 mutations occur in up to ,1% of newly diagnosed CRC, or
,10,000 cases per year.
Since MSI tumors are prone to mutation throughout the
genome, the question arises of whether the NKD1 mutations drive
tumor progression or are merely ‘‘bystander’’ mutations. A
National Cancer Institute workshop [30] proposed five criteria
to distinguish bona-fide target genes from bystander mutations,
including a) high mutation frequency, b) biallelic inactivation, c) a
Figure 3. Effect of NKD1-mutations on b-catenin and cell
proliferation. (A) Western blot of cytosolic and nuclear extracts of cells
with wild-type (CCD841) or mutant (Co115) NKD1. GAPDH and HDAC2
were probed as loading controls. (B–B0, C–C0) b-catenin (red) and DNA
(blue) distribution in CCD841 cells (B–B0) and Co115 (C–C0) cells. Arrows
designate nuclei. Merged images in B0 and C0. (D) Western blot of
cytosolic extracts of HEK-293 cells transfected with lacZ control (-), wild
type Nkd1 (WT), or indicated mutant Nkd1 construct, and probed for b-
catenin, Nkd1, and loading control GAPDH. Note that each mutant Nkd1
butnot wildtypeNkd1increasesb-cateninlevels. (E) Relativecellnumber
as a function of days post retroviral infection of CCD841 cells with empty
vector control, wild type Nkd1, or indicated Nkd1 mutant (p=0.016,
0.012, and 0.0091 for C6, C8, andR288H mutants as compared to control)
(F) Relative cell number as a function of days post retroviral infection of
Co115 cells with control or wild-type Nkd1 (p=0.022). a-Nkd1 western
blots of cell extracts, with GAPDH or b-actin loading control, are shown
below each plot in E and F.
doi:10.1371/journal.pone.0007982.g003
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growth suppression pathway in tumors without MSI through
mutation in the same gene or in another gene within the same
pathway, and e) functional suppressor studies, although the
validity of these criteria in evaluating rare or novel driver
mutations has been questioned {e.g. [6]}. Our work suggests that
the NKD1 mutations fulfill four of the five criteria – a, c, d, and e.
While the frequency of NKD1 mutation was relatively low
compared to that of known Wnt pathway genes, a mutual
exclusivity among mutations in NKD1 and other Wnt pathway
genes was statistically significant in tumor samples. The absence of
NKD1 mutations in our sample of tumors without MSI could be
due to the rare nature of specific Nkd1 truncation in tumors with
intact MMR, or due to our small sample size. However, other
genes in the Wnt signaling pathway such as APC are frequently
mutated, deleted, or methylated in tumors with intact MMR.
Biallelic inactivation of NKD1 was not observed, but the presence
of wild type Nkd1 in tumor cell lines, as well as the ability of
mutant Nkd1 to stabilize b-catenin, suggests that the NKD1
mutations might act dominantly (see below). Finally, the Nkd
family of proteins inhibits canonical Wnt signaling, and this
activity is defective in all three mutant Nkd1 proteins, suggesting
that the Nkd1 mutations alter Wnt/b-catenin signaling in vivo.
We further demonstrate that Nkd can limit Dsh/Dvl abundance
in both mammalian cell culture and fly systems, with fly Nkd
additionally having unknown but essential nuclear functions
[25,31] (Fig. 6D). We propose that the mutant human Nkd1
proteins, each with a reduced ability to bind and limit the
abundance of Dvls, increase Wnt-dependent Dvl activity, thereby
attenuating b-catenin degradation and increasing TCF-dependent
transcription of target genes that promote proliferation (Fig. 6E).
However, preventing direct Nkd1/Dvl association is apparently
insufficient to promote neoplasia, as deletion of the Dvl-binding
Nkd1 EFX motif neither rendered mutant mice susceptible to
cancer nor potentiated the frequency of Apc mutation-driven
intestinal adenomas [32]. Similarly, mice carrying N-terminal
truncating Nkd1 and/or Nkd2 mutations did not develop
spontaneous tumors [33]. Since Nkd is integral to feedback loops
in flies and vertebrates [12,34], we previously hypothesized that in
mammals a lack of Nkd activity can be compensated by redundant
feedback mechanisms, whereas in flies no such compensation is
possible given the absence of genes encoding extracellular Wnt
signaling antagonists [33].
The non-random pairing of dissimilar APC mutations in tumors
{e.g., protein truncation near the mutation cluster region (MCR)
with allelic deletion or methylation}, coupled with functional
studies of mutant Apc proteins [35,36], has suggested that the cell
must retain some ability to regulate Wnt/b-catenin signaling
during tumor progression – the so-called ‘‘just right’’ hypothesis
[37]. A consideration of the known roles for Wnt/b-catenin
signaling during colorectal carcinoma progression provides some
rationale for this hypothesis: in early stages, increased signaling
promotes stem cell renewal and alters the migration of crypt
epithelial cells [38], whereas later it acts as a switch to regulate
Figure 4. Nkd1 truncation alters subcellular localization and Dvl colocalization. (A, B) HEK-293 cells expressing HA/Flag-tagged Nkd1 (A) or
Nkd1
C8 (B) stained with a-HA (green). Nkd1 accumulates in puncta (arrows), while Nkd1
C8 is diffusely distributed in the cytoplasm. Nkd1
C6 distributed
in a pattern similar to Nkd1
C8 (not shown). (C, D) Cells co-expressing Dvl3 and wild-type (C) or C8 (D) Nkd1
GFP constructs. Nkd1-GFP (green, C) shows
near complete colocalization (arrows) with Dvl3 (red, C9), while Nkd1
C8-GFP (D) accumulates in cytoplasmic aggregates surrounded by Dvl3 (arrows).
Merged images are in C0,D 0, DNA is blue in A–D. Similar results were observed in cells coexpressing Nkd1
C8-GFP and Dvl1 or Dvl2, and in cells
expressing Nkd1
C6-GFP and Dvl1, Dvl2, or Dvl3 (not shown). (E) Salivary gland from wild-type third instar Drosophila larva stained with a-Dsh (red)
showing diffuse and punctate staining. (F–F0) A8-Gal4/UAS-Nkd
GFP salivary gland stained with a-Dsh and imaged for GFP (F) and Dsh (F9; merged in
F0). Fly Nkd
GFP relocalizes Dsh to perinuclear aggregates (arrows) similar to those observed with Nkd1
GFP/Dvl3 in C.
doi:10.1371/journal.pone.0007982.g004
NKD1 Mutations in Human Cancer
PLoS ONE | www.plosone.org 6 November 2009 | Volume 4 | Issue 11 | e7982epithelial to mesenchymal transitions during invasion and
metastasis [39]. Thus, tumor progression might require transient
up- or down-regulation of target gene expression depending on
mutational load and local environmental conditions. Given that
wild-type Nkd1 protein persists in the NKD1-mutant cell lines
tested, we hypothesize that the mutant Nkd1 proteins - each of
which retains multiple functional motifs (N-terminal myristoyla-
tion, EFX, and 30 aa motifs) - activate Wnt signaling in vivo,
perhaps analogous to the manner in which Apc proteins truncated
near the MCR activate Wnt signaling [36].
Despite the overwhelming evidence that abnormal Wnt/b-
catenin signaling causes cancer, the role of Dsh/Dvl proteins in
neoplasia remains obscure. Wnt signaling can promote Dsh/Dvl
accumulation [40], and Dvl overexpression can mimic activation of
the Wnt/b-catenin signaling axis [41], suggesting that Dvl
hyperactivity, like b-catenin stabilization due to mutation, could
be a primary cause of elevated Wnt signaling in cancer. Indeed, Dvl
amplification and overexpression has been identified in neoplasia
{e.g. lung cancer [42]}, but Dvl accumulation in cancer could also
be a secondary consequence of unopposed Wnt ligand-driven
autoactivation of signaling [43]. Given the crucial roles for Dsh/
Dvls in ‘‘non-canonical’’ Wnt pathways that govern planar-cell-
polarity and cell migration in vertebrates [44], the NKD1 mutations
might also alter Dvl activity in non-canonical Wnt pathways that
control cell polarity or migration during cancer progression. Future
experiments will focus on understanding how the mutant Nkd1
proteins alter Wnt signaling during cancer progression in vivo.
Materials and Methods
Ethics statement
This study was conducted according to the principles expressed
in the Declaration of Helsinki. The study was approved by the
Institutional Review Board of Mayo Clinic hospitals. All patients
provided written informed consent for the collection of samples
and subsequent analysis. Frog husbandry, in vitro fertilization, and
embryo culture and staging were performed according to standard
protocols and all animals were handled in strict accordance with
good animal practice as defined by the American Association for
Laboratory Animal Science, and the Xenopus studies were
approved by the Animal Care and Use committee at the
University of Pennsylvania.
CRC cell lines and tumors
DNA from 11 MSI-CRC cell lines (Co115, LS174, Lovo,
TC71, HCT15, HCT116, TC7, SW48, RKO, HCT8, and
Figure 5. Mutant Nkd1 proteins exhibit reduced Dsh/Dvl associations. (A) Y2H between Nkd1-baits and Dvl-prey assayed for growth on
triple dropout (3D+3AT) or double dropout (2D) media. Bar graphs on right show ONPG units from quantitative Y2H assay. Western blot indicates
that Nkd1 mutant proteins are of comparable abundance (not shown). (B) GST-pulldown assay of in vitro translated,
35[S]-labelled Dvl1-3 with each
GST-Nkd1 protein. Bar graph is quantitative band intensity. Coomassie-stained gel shows each GST-fusion protein, with arrowheads indicating full-
length proteins. (C) Western blots of Flag-IPs from HEK-293 cell extracts with equal amounts of each HA/Flag-tagged Nkd1, and then probed with a-
HA (upper) and a-Dvl3 (middle). b-actin is loading control (lower). Note that less Dvl3 is IP’d by Nkd1
C6 or Nkd1
C8 as compared to full-length Nkd1. No
co-IP was observed between wild-type or mutant Nkd1s and Dvl1 or Dvl2, reminiscent of the lack of stable co-IP between Drosophila Nkd and Dsh
[13].
doi:10.1371/journal.pone.0007982.g005
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without MSI (SW480 from U. Verma, UTSW; SW837, SW620,
HT29, and Caco-2, from ATCC) was isolated as described [8].
Forty primary MSI-CRC and 50 CRC without MSI were
collected at Mayo Clinic [8]. Following microdissection of tumor
cells from sections of tumor specimens, DNA was extracted using
the Easy-DNA
TM kit (Invitrogen).
Mutation detection
All NKD1 coding exons and intron/exon junctions were PCR-
amplified (sequences available upon request). Primer pairs used to
amplify the NKD1 poly(C)7 tract: 59TCTGGGGTATAGCG-
CAAGC and 59CTGAGACCTTGGCGATTGG. Methods for
PCR, denaturing high-performance liquid chromatography
(DHPLC), direct sequencing, and for detecting mutations in
AXIN2, TCF7L2, CTNNB1, and APC were as described [8,45].
Plasmids
NKD1 cDNA was isolated from a human lung cDNA library (U.
Sathyanarayana and A. Gazdar, UT Southwestern) by PCR. All
PCR reactions used Pfu polymerase. NKD1 codons in expression
constructs were as follows: Nkd1
WT 1–470; Nkd1
C6 1–287
followed by out-of-frame sequence for codons 288–345; Nkd1
C8
1–287 followed by out-of frame sequence for codons 288–298;
Nkd1
R288H 1–470 with Arg #288 changed to His. For expression
in HEK-293 cells, NKD1 cDNAs with a 39 HA-epitope tag
(YPYDVPDY) were PCR-amplified and cloned into pCMV-4B
(Sigma-Aldrich; 39 Flag-tag) to generate Nkd1 constructs with C-
terminal HA/Flag-tags. For Nkd1
GFPs, Nkd1 fragments were PCR
amplified and cloned into pEGFP-N3 (Clontech). For Xenopus
injections, each HA/Flag-tagged Nkd1 fragment was subcloned
into pCS2+ (http://sitemaker.umich.edu/dlturner.vectors). Hu-
man Dvl1, Dvl2, and Dvl3 were expressed via the CMV promoter
in pCDNA3 (Invitrogen). For the TOPflash assay, mouse Dvl2
cDNA was PCR-amplified and cloned into pEGFP-N1 (Clontech).
For cell proliferation assays, Nkd1 fragments were PCR-amplified
and cloned into pBABE-puro. Retroviral transductions were
performed as described (http://www.addgene.org/pgvec1?f=
c&cmd=findpl&identifier=1764).
Xenopus injections
pCS2+ EGFP, XWnt8, and Nkd1 (wild type/mutant) plasmids
were linearized and mRNAs transcribed with SP6 mMessage
mMachine (Ambion). Axis duplication assays were performed by
injecting 1 pg XWnt8 +/2250 pg NKD1 (wild-type or mutant)
with 200 pg EGFP (lineage tracer) mRNAs into one ventral
blastomere at the 4-cell stage. Embryos were collected at stage 10,
and lysates were analyzed by western blot with a-HA (Sigma) at
1:1,000. The remaining embryos were cultured until stage 35,
fixed, and scored for axis phenotype: Single axis: wild-type; Single
axis (short A/P): embryos without secondary axes, but with
marked reduction in the A/P axis; Partial Axis Duplication:
embryos with ectopic trunk structures, but no ectopic head tissues;
Full Axis Duplication: embryos bearing ectopic trunk and anterior
structures including cement gland and at least one eye or forebrain
vesicle.
TOPflash assay
HEK-293 cells were cultured in DMEM+10% horse serum,
100 u/ml pen-strep, 1 mM sodium pyruvate, 2 mM L-glutamine,
and 0.1 mM nonessential amino acids. 5610
4 cells wereseededinto
each well of a 24-well plate and co-transfected with 0.3 mg plasmid
including 0.1 mg TOPflash (Upstate Biotechnology) +/20.1 mg
Figure 6. Mutant Nkd1s do not limit the abundance of Dsh/Dvl
as well as wild type Nkd1. (A–A0) 71B-Gal4/UAS-Nkd
GFP third-instar
Drosophila salivary gland stained with a-Dsh and imaged for GFP (A)
and Dsh (A9) distributions (merged image in A0). Quantitation of Dsh
pixel intensity (white box in A9) reveals reduced staining in cell
expressing more (right, green asterisk) Nkd
GFP than in adjacent cell
expressing less Nkd
GFP. (B) Western blots of HEK-293 cells transfected
with indicated Flag/HA-tagged Nkd1 and Dvl1, Dvl2, or Dvl3 constructs
probed with a-HA, a-Dvl1-3, and a-btubulin as a loading control. Each
of the Dvl1-3 blots was loaded with equal amounts of extract, as
confirmed by probing each blot with a-btubulin. (C) HEK-293 cells co-
expressing Nkd1
GFP and Dvl1, stained with a-Dvl1, and imaged for GFP
(green), Dvl1 (red), and DNA (blue) showing fine punctate Dvl1
distribution in cells expressing low to absent Nkd1
GFP (white arrow).
In adjacent cells expressing Nkd1
GFP, Dvl1 is relocalized to Nkd1
GFP/Dvl1
aggregates (yellow arrow), with loss of fine punctate Dvl1 staining
(arrowheads). (D, E) Models of Nkd function in Drosophila (D) and NKD1-
mutant CRC (E). Double lines: upper=plasma membrane; lower=nuclear
membrane. (D) Fly Wg(Wnt) binds Fz/Arrow(Lrp5/6) receptors, which
inhibits the Apc/Axin/CK1/GSK3b complex that promotes degradation of
Arm(b-catenin). Arm complexes with Pan(TCF) to activate target genes
including nkd. Nkd promotes Dsh turnover to partially inhibit signaling,
and employs the nuclear import factor Imp-a3 to enter the nucleus and
further inhibit signaling through unknown mechanisms [31]. (E) In NKD1-
mutant CRC, the mutant Nkd1 protein no longer binds and promotes Dvl
turnover, stabilizing b-catenin and activating TCF-dependent transcrip-
tion of target genes.
doi:10.1371/journal.pone.0007982.g006
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GFP +/20.1 mg each pCMV-Nkd1 expression con-
struct or empty vector +1 ng pRL-TK as a control for transfection
efficiency. TCF reporter activity was measured 36 hr post-
transfection with the Dual-Luciferase Reporter Assay System
(Promega), and luciferase activities were measured using a Lumat
LB-9507 luminometer (Berthold). Assays were performed in
triplicate.
Detection of endogenous Nkd1 and b-catenin
Whole cell lysates:2 610
6 cells were harvested with 5 mM EDTA
in PBS, pelleted at 300 g for 5 min at 4uC, lysed in NETN-100
lysis buffer (100 mM NaCl, 1 mM EDTA, 20 mM Tris pH 8.0,
0.5% NP-40 containing complete protease inhibitor cocktail
(Roche), 10 mM NaF, and 10 mM b-glycerolphosphate), and
lysates were centrifuged at 10,000 g for 10 min at 4uC. Protein
concentrations were determined by Bradford assay (Bio-Rad).
Supernatants were resolved by 10% SDS-PAGE. Triton X-100
lysates:3 610
5 cells were rinsed in PBS, and incubated with 0.5 ml
50 mM MES buffer, pH 6.8 (2.5 mM EGTA, 5 mM MgCl2 and
0.5%Triton X-100) for 3 min at room temperature. Triton X-100-
soluble lysates were then aspirated into a fresh tube. The
remaining material, scraped into 0.5 ml MES buffer and vortexed
for 1 min, constituted the insoluble fraction. 50 mg each extract
was resolved by 10% SDS-PAGE. After Hybond membrane (GE
Healthcare) transfer, western blot was performed at 4uC overnight
with rabbit polyclonal a-Nkd1 (Ab1, Cell Signaling Technology) at
1:1,000 with 0.1% Triton X-100 and 5% nonfat powdered milk
(as blocking agent) in TBS, followed by incubation at room
temperature for 1 hr with HRP-conjugated secondary antibodies
(Pierce) at 1:1,000. Signals were visualized by the SuperSignal
West Chemiluminescent Substrate kit (Pierce). The specificity of a-
Nkd1 antisera was confirmed by western blot of nkd1-mutant
tissues [33]. For Fig. 3D, HEK-293T cells were transfected with
4 mg each plasmid (wild type or each mutant Nkd1), and 48 hrs
later subcellular fractionation was performed as described [46].
Concentrations of extract fractions were determined by BCA
Protein Assay Kit (Pierce) and confirmed by immunoblots.
Cell proliferation assay
2610
3 cells/well were plated in triplicate into 96-well plates and
infected 2 hrs later with retrovirus expressing wild-type or each
mutant Nkd1, or retrovirus control (titers$10
7/ml). Medium was
replaced with 100 ml fresh medium 24 hrs post infection. Cell
numbers were counted using the MTS assay (Promega).
In vitro protein binding assays
Nkd constructs were cloned into the pAS2-1 bait vector, Dvl
constructs into the pAct2 prey vector (Clontech). Yeast-two-hybrid
assay and yeast extract preparation was as described [47] in the
yeast reporter strain Y190 under double dropout (2D: -Leu-Trp)
and triple dropout (3D: -Leu-Trp-His) conditions with 50 mM 3-
amino-1,2,4-triazole (3-AT) (Sigma) added to suppress growth
under 3D. Four independent experiments were performed in
triplicate for each plasmid combination.
Lysates containing each GST-Nkd fusion protein were prepared
from BL21pLys E. coli (Amersham Biosciences). Each lysate was
incubated with glutathione-Sepharose-4B beads for 1 hr at 4uC,
and then washed 3x with DT80 buffer [47].
35[S]-Methionine-
labeled Dvl1, Dvl2, and Dvl3 proteins were synthesized using TNT
T7 coupled reticulocyte lysate system (Promega) and incubated with
beads for 2 hr at 4uC in DT80 buffer. The beads were washed 4x
with DT300 buffer, and labeled proteins were eluted in SDS-PAGE
sample buffer, boiled 5 min, and then separated by SDS-PAGE on
8% gels. Gels were vacuum dried, and Dvl1-3 protein bands were
quantitated using a Typhoon phosphorimager with ImageQuant
software (Molecular Dynamics).
Nkd/Dsh transfection and immunoprecipitations
2.2610
6 HEK-293 cells cultured in DMEM+10%FBS were
transfected with 12.5 mg HA/Flag-tagged Nkd1 construct and
12.5 mg Dvl1, Dvl2, or Dvl3 using Transfectamine (Invitrogen).
24 hr post-transfection, cells were harvested with 5 mM EDTA in
PBS, pelleted at 300 g for 5 min at 4uC, and then lysed in NETN-
100 (described above) for 1 hr on ice. Lysate was centrifuged at
10,000 g for 5 min at 4uC, and extract volumes containing equal
amounts of wild-type and each mutant Nkd1 protein (as
determined by quantitating a western blot with loaded with equal
volumes of total protein extract) were immunoprecipitated (IP’d)
using the M2 a-Flag IP kit (Sigma-Aldrich). IPs were eluted with
150 ng/ml 3X-Flag peptide (Sigma-Aldrich) followed by western
blot as described above. Antibodies used at 1:1,000: mouse mAb
a-HA HA.11 (Covance); mouse mAb a-Dvl1(3F12; Santa Cruz
Biotechnology); rabbit polyclonal a-Dvl2 and a-Dvl3 (#3216,
#3218; Cell Signaling Technology). In Fig. 6B, 3.3610
5 HEK-
293 cells were transfected with 0.2 mg each HA/Flag-tagged Nkd1
and 0.2 mg Dvl1, Dvl2, or Dvl3. 24 hr-post transfection, cells were
harvested and whole cell lysates were prepared as described above.
a-Dvl Abs were used at 1:1000; mAb a-btubulin (TU27, Covance
Research Products) 1:2,500. Control Abs were used as follows: a-
bactin (#A5541, Sigma,) 1:5,000; a-GAPDH (25778, Santa Cruz
Biotechnology) 1:5,000; a-HDAC2 (6296, Santa Cruz Biotech-
nology) 1:500.
Immunofluorescence staining and microscopy
For b-catenin detection, CRC cell lines cultured on 12-well
slides (Erie Scientific Co.) were fixed in 4% formaldehyde in PBS
for 15 min, permeabilized with 0.2% Triton X-100 (1xPBS) for
5 min, and blocked in 3% BSA (1xPBS) for 30 min. The cells were
incubated with mouse monoclonal a-b-catenin antibody (BD
Transduction Laboratories) followed by Alexa 594-conjugated
donkey anti-mouse IgG (Molecular Probes). Images were acquired
with an Olympus BX41.
For detection of transfected Nkd/Dsh, 4610
4 HEK-293 cells in
each well of poly-D-lysine–coated glass 8-chambered slides (BD
Biosciences) were transfected with 0.2 mg each tagged Nkd1
plasmid construct +/20.2 mg Dvl1, Dvl2, or Dvl3 plasmid using
Lipofectamine 2000 (Invitrogen). 36 hrs post-transfection, slides
were fixed with 4% paraformaldehyde for 10 min and permea-
bilized with 0.2% Triton X-100 in PBS. After blocking with 10%
BSA (Sigma-Aldrich) in PBS for 1 hr, cells were incubated with
each a-Dvl Ab at 4uC overnight. Antibody dilutions: a-Dvl1
(3F12) 1:100; a-Dvl2 (#3216) 1:250; a-Dvl3 (#3218) 1:250; a-HA
(HA.11) 1:1,000. Mouse mAbs were incubated with TRITC-
conjugated rabbit a-mouse IgG (Invitrogen) at 1:200 in 10%
BSA/PBS, while rabbit polyclonal Abs were incubated with
Rhodamine Red-X conjugated goat a-rabbit IgG (Invitrogen) at
1:200. Images were acquired on a Nikon-C1 confocal. The
specificity of each a-Dvl antisera was verified by lack of staining in
untransfected HEK-293 cells, and in Dvl-transfected cells
incubated minus each Dvl antibody but incubated with the
fluorescent secondary Ab.
Drosophila experiments
Salivary glands from wild-type, A8-Gal4/UAS-Nkd
GFP,o r71B-Gal4/
UASNkd
GFP third instar larvae were fixed for 10 min in PBS+4%
paraformaldehyde at 4uC, then stained with a-Dsh at 1:100 and Alexa-
588 conjugated a-rabbit secondary Ab at 1:500 (Jackson Immunor-
NKD1 Mutations in Human Cancer
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intensities were analyzed with ImageJ (NIH).
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